Pre-order Enquiry
Request Free Sample
Global Personalized Medicine for Cancer Market Research Report 2022
SKU ID : QYR-21177357 | Publishing Date : 29-Jun-2022 | No. of pages : 86
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Personalized Medicine for Cancer Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicine for Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Immunotherapy
1.2.3 Targeted Therapy
1.2.4 Chemotherapy
1.2.5 Hormone Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Personalized Medicine for Cancer Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Blood Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Skin Cancer
1.3.7 Lung Cancer
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicine for Cancer Market Perspective (2017-2028)
2.2 Personalized Medicine for Cancer Growth Trends by Region
2.2.1 Personalized Medicine for Cancer Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Personalized Medicine for Cancer Historic Market Size by Region (2017-2022)
2.2.3 Personalized Medicine for Cancer Forecasted Market Size by Region (2023-2028)
2.3 Personalized Medicine for Cancer Market Dynamics
2.3.1 Personalized Medicine for Cancer Industry Trends
2.3.2 Personalized Medicine for Cancer Market Drivers
2.3.3 Personalized Medicine for Cancer Market Challenges
2.3.4 Personalized Medicine for Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicine for Cancer Players by Revenue
3.1.1 Global Top Personalized Medicine for Cancer Players by Revenue (2017-2022)
3.1.2 Global Personalized Medicine for Cancer Revenue Market Share by Players (2017-2022)
3.2 Global Personalized Medicine for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicine for Cancer Revenue
3.4 Global Personalized Medicine for Cancer Market Concentration Ratio
3.4.1 Global Personalized Medicine for Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine for Cancer Revenue in 2021
3.5 Personalized Medicine for Cancer Key Players Head office and Area Served
3.6 Key Players Personalized Medicine for Cancer Product Solution and Service
3.7 Date of Enter into Personalized Medicine for Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine for Cancer Breakdown Data by Type
4.1 Global Personalized Medicine for Cancer Historic Market Size by Type (2017-2022)
4.2 Global Personalized Medicine for Cancer Forecasted Market Size by Type (2023-2028)
5 Personalized Medicine for Cancer Breakdown Data by Application
5.1 Global Personalized Medicine for Cancer Historic Market Size by Application (2017-2022)
5.2 Global Personalized Medicine for Cancer Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Personalized Medicine for Cancer Market Size (2017-2028)
6.2 North America Personalized Medicine for Cancer Market Size by Country (2017-2022)
6.3 North America Personalized Medicine for Cancer Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Personalized Medicine for Cancer Market Size (2017-2028)
7.2 Europe Personalized Medicine for Cancer Market Size by Country (2017-2022)
7.3 Europe Personalized Medicine for Cancer Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicine for Cancer Market Size (2017-2028)
8.2 Asia-Pacific Personalized Medicine for Cancer Market Size by Country (2017-2022)
8.3 Asia-Pacific Personalized Medicine for Cancer Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Personalized Medicine for Cancer Market Size (2017-2028)
9.2 Latin America Personalized Medicine for Cancer Market Size by Country (2017-2022)
9.3 Latin America Personalized Medicine for Cancer Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicine for Cancer Market Size (2017-2028)
10.2 Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2017-2022)
10.3 Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Personalized Medicine for Cancer Introduction
11.1.4 Bayer Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.1.5 Bayer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Personalized Medicine for Cancer Introduction
11.2.4 GlaxoSmithKline Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.2.5 GlaxoSmithKline Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Personalized Medicine for Cancer Introduction
11.3.4 Novartis Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.3.5 Novartis Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Personalized Medicine for Cancer Introduction
11.4.4 Sanofi Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.4.5 Sanofi Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Personalized Medicine for Cancer Introduction
11.5.4 Pfizer Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.5.5 Pfizer Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Personalized Medicine for Cancer Introduction
11.6.4 Amgen Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.6.5 Amgen Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Personalized Medicine for Cancer Introduction
11.7.4 Merck Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.7.5 Merck Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Detail
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Introduction
11.8.4 Bristol-Myers Squibb Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Ariad Pharmaceuticals (Takeda)
11.9.1 Ariad Pharmaceuticals (Takeda) Company Detail
11.9.2 Ariad Pharmaceuticals (Takeda) Business Overview
11.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Introduction
11.9.4 Ariad Pharmaceuticals (Takeda) Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.9.5 Ariad Pharmaceuticals (Takeda) Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Detail
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Personalized Medicine for Cancer Introduction
11.10.4 Eli Lilly Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.10.5 Eli Lilly Recent Development
11.11 Roche
11.11.1 Roche Company Detail
11.11.2 Roche Business Overview
11.11.3 Roche Personalized Medicine for Cancer Introduction
11.11.4 Roche Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.11.5 Roche Recent Development
11.12 Boehringer Ingelheim
11.12.1 Boehringer Ingelheim Company Detail
11.12.2 Boehringer Ingelheim Business Overview
11.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Introduction
11.12.4 Boehringer Ingelheim Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.12.5 Boehringer Ingelheim Recent Development
11.13 Johnson and Johnson
11.13.1 Johnson and Johnson Company Detail
11.13.2 Johnson and Johnson Business Overview
11.13.3 Johnson and Johnson Personalized Medicine for Cancer Introduction
11.13.4 Johnson and Johnson Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.13.5 Johnson and Johnson Recent Development
11.14 Teva Pharmaceuticals
11.14.1 Teva Pharmaceuticals Company Detail
11.14.2 Teva Pharmaceuticals Business Overview
11.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Introduction
11.14.4 Teva Pharmaceuticals Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.14.5 Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Personalized Medicine for Cancer Market Research Report 2022
List of TablesTable 1. Global Personalized Medicine for Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Hormone Therapy
Table 6. Key Players of Others
Table 7. Global Personalized Medicine for Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Personalized Medicine for Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Personalized Medicine for Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Personalized Medicine for Cancer Market Share by Region (2017-2022)
Table 11. Global Personalized Medicine for Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Personalized Medicine for Cancer Market Share by Region (2023-2028)
Table 13. Personalized Medicine for Cancer Market Trends
Table 14. Personalized Medicine for Cancer Market Drivers
Table 15. Personalized Medicine for Cancer Market Challenges
Table 16. Personalized Medicine for Cancer Market Restraints
Table 17. Global Personalized Medicine for Cancer Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Personalized Medicine for Cancer Market Share by Players (2017-2022)
Table 19. Global Top Personalized Medicine for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine for Cancer as of 2021)
Table 20. Ranking of Global Top Personalized Medicine for Cancer Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Personalized Medicine for Cancer Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Personalized Medicine for Cancer Product Solution and Service
Table 24. Date of Enter into Personalized Medicine for Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Personalized Medicine for Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Personalized Medicine for Cancer Revenue Market Share by Type (2017-2022)
Table 28. Global Personalized Medicine for Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Personalized Medicine for Cancer Revenue Market Share by Type (2023-2028)
Table 30. Global Personalized Medicine for Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Personalized Medicine for Cancer Revenue Market Share by Application (2017-2022)
Table 32. Global Personalized Medicine for Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Personalized Medicine for Cancer Revenue Market Share by Application (2023-2028)
Table 34. North America Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Personalized Medicine for Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Personalized Medicine for Cancer Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 44. Bayer Company Detail
Table 45. Bayer Business Overview
Table 46. Bayer Personalized Medicine for Cancer Product
Table 47. Bayer Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 48. Bayer Recent Development
Table 49. GlaxoSmithKline Company Detail
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline Personalized Medicine for Cancer Product
Table 52. GlaxoSmithKline Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 53. GlaxoSmithKline Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Personalized Medicine for Cancer Product
Table 57. Novartis Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Sanofi Company Detail
Table 60. Sanofi Business Overview
Table 61. Sanofi Personalized Medicine for Cancer Product
Table 62. Sanofi Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 63. Sanofi Recent Development
Table 64. Pfizer Company Detail
Table 65. Pfizer Business Overview
Table 66. Pfizer Personalized Medicine for Cancer Product
Table 67. Pfizer Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Amgen Company Detail
Table 70. Amgen Business Overview
Table 71. Amgen Personalized Medicine for Cancer Product
Table 72. Amgen Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. Merck Company Detail
Table 75. Merck Business Overview
Table 76. Merck Personalized Medicine for Cancer Product
Table 77. Merck Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Bristol-Myers Squibb Company Detail
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Personalized Medicine for Cancer Product
Table 82. Bristol-Myers Squibb Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Ariad Pharmaceuticals (Takeda) Company Detail
Table 85. Ariad Pharmaceuticals (Takeda) Business Overview
Table 86. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product
Table 87. Ariad Pharmaceuticals (Takeda) Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 88. Ariad Pharmaceuticals (Takeda) Recent Development
Table 89. Eli Lilly Company Detail
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Personalized Medicine for Cancer Product
Table 92. Eli Lilly Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 93. Eli Lilly Recent Development
Table 94. Roche Company Detail
Table 95. Roche Business Overview
Table 96. Roche Personalized Medicine for CancerProduct
Table 97. Roche Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 98. Roche Recent Development
Table 99. Boehringer Ingelheim Company Detail
Table 100. Boehringer Ingelheim Business Overview
Table 101. Boehringer Ingelheim Personalized Medicine for CancerProduct
Table 102. Boehringer Ingelheim Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 103. Boehringer Ingelheim Recent Development
Table 104. Johnson and Johnson Company Detail
Table 105. Johnson and Johnson Business Overview
Table 106. Johnson and Johnson Personalized Medicine for CancerProduct
Table 107. Johnson and Johnson Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 108. Johnson and Johnson Recent Development
Table 109. Teva Pharmaceuticals Company Detail
Table 110. Teva Pharmaceuticals Business Overview
Table 111. Teva Pharmaceuticals Personalized Medicine for CancerProduct
Table 112. Teva Pharmaceuticals Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 113. Teva Pharmaceuticals Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Medicine for Cancer Market Share by Type: 2021 VS 2028
Figure 2. Immunotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Hormone Therapy Features
Figure 6. Others Features
Figure 7. Global Personalized Medicine for Cancer Market Share by Application in 2021 & 2028
Figure 8. Breast Cancer Case Studies
Figure 9. Blood Cancer Case Studies
Figure 10. Gastrointestinal Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Skin Cancer Case Studies
Figure 13. Lung Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Personalized Medicine for Cancer Report Years Considered
Figure 16. Global Personalized Medicine for Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Personalized Medicine for Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Personalized Medicine for Cancer Market Share by Region: 2021 VS 2028
Figure 19. Global Personalized Medicine for Cancer Market Share by Players in 2021
Figure 20. Global Top Personalized Medicine for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine for Cancer as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Personalized Medicine for Cancer Revenue in 2021
Figure 22. North America Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. North America Personalized Medicine for Cancer Market Share by Country (2017-2028)
Figure 24. United States Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Personalized Medicine for Cancer Market Share by Country (2017-2028)
Figure 28. Germany Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Personalized Medicine for Cancer Market Share by Region (2017-2028)
Figure 36. China Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Personalized Medicine for Cancer Market Share by Country (2017-2028)
Figure 44. Mexico Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Personalized Medicine for Cancer Market Share by Country (2017-2028)
Figure 48. Turkey Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Saudi Arabia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Bayer Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 52. Novartis Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 53. Sanofi Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 54. Pfizer Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 55. Amgen Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 56. Merck Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 58. Ariad Pharmaceuticals (Takeda) Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 59. Eli Lilly Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 62. Johnson and Johnson Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 63. Teva Pharmaceuticals Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Keyplayers in Global Personalized Medicine for Cancer Market Research Report 2022
BayerGlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Merck
Bristol-Myers Squibb
Ariad Pharmaceuticals (Takeda)
Eli Lilly
Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals
